Corporate Governance

The Board of Directors of BridgeBio Pharma (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Governance Documents

state disclosures

Colorado Disclosure Act

Colo. Rev. Stat. § 12-280-308 requires pharmaceutical manufacturers, when engaging in prescription drug marketing, to provide the wholesale acquisition cost (WAC) of the drug to Colorado prescribers. Under Colorado law, the names of generic prescription drugs (if available) from the same therapeutic class (ie, same or similar mechanism of action used to treat a specific condition) shall also be provided.

Information for Colorado Prescribers of Prescription Drugs

Connecticut Disclosure Act

Connecticut Public Act No. 23-171 requires the disclosure of the list price of a legend drug when a pharmaceutical representative provides information concerning such legend drug to prescribing practitioners or pharmacists, based on the dose and quantity of such legend drug as described in the medication package insert.

Information for Connecticut Prescribers of Prescription Drugs

Vermont Disclosure Act

Vermont law 33 V.S.A. §2005a mandates that pharmaceutical manufacturers disclose to Vermont physicians and other prescribers the average wholesale price (AWP) of drugs they market within the state as well as the prices of other drugs in the same therapeutic class. Under Vermont law, "therapeutic class" is defined as the therapeutic class listed in the 2004 American Hospital Formulary Service Pharmacologic-Therapeutic Classification published by the American Society of Health System Pharmacists (available at https://www.ashp.org).

BridgeBio, inc. has listed these therapeutic class prices in Long Form Disclosures as required under Vermont Law.

Information for Vermont Prescribers of Prescription Drugs (Short Form)
Information for Vermont Prescribers of Prescription Drugs (Long Form)

Annual Report

Board of Directors

Committee Charters

committee composition

Audit Committee Compensation Committee Nominating & Corporate Governance Committee
Randy Scott, Ph.D. Audit Committee
Andrew Lo, Ph.D. Nominating & Corporate Governance Committee
Eric Aguiar, M.D. Audit Committee
Douglas Dachille Nominating & Corporate Governance Committee
Ronald J. Daniels Compensation Committee
Andrea Ellis Audit Committee
Fred Hassan Compensation Committee
Ali Satvat Compensation Committee Nominating & Corporate Governance Committee
Hannah Valantine, M.D. Nominating & Corporate Governance Committee
= Chairperson = Member

Print Page

Email Alerts

RSS Feeds

Contact IR